From Signal to Insight: Data Pipelines and the Role of AI
Useful data arise long before the model. A pipeline is needed to filter artefacts, manage sensor drift, recognise real-world conditions of use and produce clinically interpretable features. TheAI is not a special effect but the accelerator that uncovers correlations across long time series and builds risk indices and proposes priorities for care. Algorithms must explain what they have “seen”: an alert without a rationale is not acceptable in clinical practice. A valid platform is recognised by the reproducibility of results across cohorts and on the ability to learn without turning the patient into a permanent beta tester.
Certification, safety and interoperability: the non-negotiable triangle
A device or software that influences clinical decisions falls within the scope of the Regulation (EU) 2017/745 (MDR). This means correct classification, risk management, clinical evaluation and post-market surveillance. If decision-support software is involved, standards for medical-software lifecycle, requirements traceability and independent verification. Security is not merely encrypting traffic: it is data governance, access control, verifiable logs, environment segmentation, incident-response plans. Theinteroperability is not a favour to technology; it is a clinician’s right: HL7/FHIR profiles, shared vocabularies, stable mapping with hospital information systems; no data “prisons”.
From prevention to follow-up: what really changes
When a platform works, three things happen. The decisions arrive earlier, because the alert threshold is based on robust indicators rather than episodic impressions. The quality of life improves, because monitoring supports rather than harasses; the technology disappears and the benefits remain. Finally, theorganisation learns: teams build evidence-based routines, workload is distributed more effectively, and clinical time is used where it ‘creates outcomes’. This is the difference between “having an app” and practise telemedicine.
Explore the topics
How to collaborate: what to bring to the table
To rapidly assess an initiative, we ask for a clear use question, the list of sensors used with specifications and certifications, the data pipeline and quality metrics, the description of thealgorithm (even at a high level) with validation criteria, the clinical-operational protocol with roles and intervention thresholds. In return, we provide a fit check technical-clinical, the definition of the TRL pathway, support on MDR/compliance and, where indicated, pathways to industrial scalability.
Frequently Asked Questions
The questions you ask us most often
We start from risk classification and by the clinical scope of use. Requirements, risk management, clinical evaluation, software validation where present, and a plan for post-market surveillance. Documentation accompanies the entire lifecycle; compliance is not an event, it is a process.
It means speaking the standard languages of the sector (e.g. HL7/FHIR), maintain stable mappings, guarantee import/export without lock-in, and allow clinicians to see the data within its context (EHR, LIS, PACS) without duplication or manual copying.
With privacy by design and security by design: data minimisation, encryption in transit and at rest, access control, environment segmentation, audit trails and incident-response procedures. Roles and legal bases are made explicit; suppliers are also assessed for business continuity.